XML 88 R69.htm IDEA: XBRL DOCUMENT
v3.8.0.1

Business Segment Information - Schedule of Depreciation and Amortization by Reporting Segment (Detail) - USD ($) $ in Thousands | 12 Months Ended
--- | ---
Dec. 31, 2017 | Dec. 31, 2016 | Dec. 31, 2015
Segment Reporting Information [Line Items] |  |  |
Depreciation and amortization | $ 20,124 | $ 20,841 | $ 20,923
Operating Segments [Member] | BioStim [Member] |  |  |
Segment Reporting Information [Line Items] |  |  |
Depreciation and amortization | 2,133 | 2,754 | 2,933
Operating Segments [Member] | Extremity Fixation [Member] |  |  |
Segment Reporting Information [Line Items] |  |  |
Depreciation and amortization | 6,040 | 5,742 | 6,636
Operating Segments [Member] | Spine Fixation [Member] |  |  |
Segment Reporting Information [Line Items] |  |  |
Depreciation and amortization | 6,949 | 8,118 | 10,050
Operating Segments [Member] | Biologics [Member] |  |  |
Segment Reporting Information [Line Items] |  |  |
Depreciation and amortization | 752 | 1,011 | 1,157
Corporate, Non-Segment [Member] |  |  |
Segment Reporting Information [Line Items] |  |  |
Depreciation and amortization | $ 4,250 | $ 3,216 | $ 147

X
- Definition The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3602-108585 + Details
Name: | us-gaap_DepreciationDepletionAndAmortization
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_SegmentReportingInformationLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=ofix_BioStimMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=ofix_ExtremityFixationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=ofix_SpineFixationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=ofix_BiologicsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |